Merit Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.3M Buy
23,637
+2,824
+14% +$155K 0.01% 667
2025
Q1
$1.47M Buy
20,813
+15,994
+332% +$1.13M 0.02% 517
2024
Q4
$317K Buy
+4,819
New +$317K 0.01% 904